NCT03892720View on ClinicalTrials.gov

Stereotactic Body Radiation Therapy Using HyperArc in Treating Patients With Recurrent Head and Neck Cancer

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

March 27, 2019

Primary Completion Date

August 21, 2024

Study Completion Date

August 21, 2024

Conditions
Recurrent Head and Neck Carcinoma
Interventions
OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

RADIATION

Stereotactic Body Radiation Therapy

Undergo SBRT

Trial Locations (1)

90095

UCLA / Jonsson Comprehensive Cancer Center, Los Angeles

All Listed Sponsors
collaborator

Varian, a Siemens Healthineers Company

INDUSTRY

lead

Jonsson Comprehensive Cancer Center

OTHER

NCT03892720 - Stereotactic Body Radiation Therapy Using HyperArc in Treating Patients With Recurrent Head and Neck Cancer | Biotech Hunter | Biotech Hunter